“Adapting prescribing criteria for amyloid‐targeted antibodies for adults with Down syndrome” published in the journal of the Alzheimer’s Association Drawing attention to policies currently preventing people with intellectual disabilities from […]
Webinars presentados por la Fundación Catalana Síndrome de Down (FCSD).Source: Fundación Catalana Síndrome de Down (FCSD)
Subclinical hypothyroidism (SH) is particularly frequent in individuals with Down syndrome (DS). Despite the amount of evidence suggesting SH is associated with psychopathological symptoms and sleep problems in general population, […]
Fact sheet about dementia and intellectual disabilities from the National Task Group on Intellectual Disabilities and Dementia Practices (NTG).Source: National Task Group on Intellectual Disabilities and Dementia Practices
Medicare, Medicaid and Dual Enrollment for Adults with IDD Boston University School of Public Health recently published an article in Health Services Research Journal entitled Medicare, Medicaid, and Dual Enrollment […]
Individuals with Down syndrome (DS) are living longer than they used to. This trend has led to a heightened prevalence of DS-associated Alzheimer’s disease (DS-AD) in the adult DS population. […]
